Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

.blurhash-client-img { display: none !important; }

Open Access

|Mar 2019

Authors

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2019-0013 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Language: English

Page range: 85 - 95

Submitted on: Aug 30, 2018

Accepted on: Sep 20, 2018

Published on: Mar 3, 2019

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2019 Martina Rebersek, Tanja Mesti, Marko Boc, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.